ArticlePloS one2012

Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens.

Silvia Ratto-Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.